Prostate cancer is the second highest cause of cancer death in men. Lung cancer is the first. More than 230,00 new cases of prostate cancer are diagnosed each year in the U.S.A. alone. Prior to the prostate specific antigen test 75% of prostate cancer patients were diagnosed in the later stages and were uncurable. Now, advanced cancer is only found in about 25% of newly diagnosed cases.
High Intensity Focused Ultrasound (HIFU) is a brand new, cutting edge prostate cancer treatment technology acoustic ablatherm technique that uses ultrasound to eliminate the deep-seated tissue of prostate cancer with absolute accuracy. High Intensity Focused Ultrasound aims soundwaves at the specific area. This increases the temperature in the targetted zone and destroys the cancerous tissue. High intensity focused ultrasound reduces common side effects like subsequent impotence and incontinence. The procedure takes one to three hours and is performed as out patient surgery. This is a one time procedure and an epidural is used. High intensity focused ultrasound doesn’t rely on radiation, so it can be carried out again with no risk of damaging healthy tissue. It can also be used when other prostate cancer treatments don’t work.
High intensity focused ultrasound has proven advantages over past treatments for prostate cancer and other prostate diseases. To find out if you qualify for HIFU, you will need a detailed medital history that includes a recent PSA, Gleason score, prostate size and volume, the treatment strategy your physican has prescribed so far and any other medical information that may be relevant.
[...] the deep-seated tissue of prostate cancer with absolute accuracy. … article continues at Sophia brought to you by cancer.medtrials.info and [...]